Royalty Pharma
RPRX
#624
Rank
โ‚ฌ35.51 B
Marketcap
61,77ย โ‚ฌ
Share price
-1.22%
Change (1 day)
81.28%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): 1,32ย โ‚ฌ

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is 1,39ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 1,63ย โ‚ฌ a decrease over its 2024 EPS that were of 1,75ย โ‚ฌ.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)1,32ย โ‚ฌ-18.9%
20251,63ย โ‚ฌ-7.1%
20241,75ย โ‚ฌ
20201,38ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
2,46ย โ‚ฌ 76.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
28,13ย โ‚ฌ 1,920.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
4,72ย โ‚ฌ 238.73%๐Ÿ‡บ๐Ÿ‡ธ USA